The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Olson Eric R since 2017.
This trader's CIK number is 1678149.
At the time of last reporting, Olson Eric R was the Chief Scientific Officer of Syros Pharmaceuticals, Inc.. (stock ticker symbol SYRS).
Also see all insider trading activities at Syros Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2023 | SYRS | 0 | $0 | 689 | $2,411 | 2,000 | $0 |
| 2022 | SYRS | 0 | $0 | 2,208 | $7,655 | 0 | $0 |
| 2021 | SYRS | 0 | $0 | 3,628 | $34,371 | 3,628 | $3,664 |
| 2020 | SYRS | 0 | $0 | 18,949 | $235,962 | 15,750 | $15,906 |
| 2017 | SYRS | 0 | $0 | 15,000 | $332,095 | 15,000 | $15,150 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-07-17 | SYRS | Sale | 689 | 3.50 | 2,411 |
| 2023-03-31 | SYRS | Option Ex | 2,000 | .00 | 0 |
| 2022-01-05 | SYRS | Sale | 2,208 | 3.47 | 7,655 |
| 2021-03-15 | SYRS | Option Ex | 3,628 | 1.01 | 3,664 |
| 2021-03-15 | SYRS | Sale | 3,628 | 9.47 | 34,371 |
| 2020-08-17 | SYRS | Option Ex | 4,963 | 1.01 | 5,012 |
| 2020-08-18 | SYRS | Option Ex | 10,787 | 1.01 | 10,894 |
| 2020-08-17 | SYRS | Sale | 4,963 | 13.00 | 64,519 |
| 2020-08-18 | SYRS | Sale | 10,787 | 13.00 | 140,231 |
| 2020-07-07 | SYRS | Sale | 1,753 | 11.72 | 20,538 |
| 2020-02-18 | SYRS | Sale | 1,446 | 7.38 | 10,674 |
| 2017-08-07 | SYRS | Option Ex | 2,500 | 1.01 | 2,525 |
| 2017-08-07 | SYRS | Sale | 2,500 | 23.59 | 58,970 |
| 2017-07-25 | SYRS | Option Ex | 12,500 | 1.01 | 12,625 |
| 2017-07-25 | SYRS | Sale | 12,500 | 21.85 | 273,125 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Olson Eric R (Chief Scientific Officer of Syros Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.